3-HYDROXYOXINDOLE DERIVATIVES AS CRHR2 ANTAGONIST
The present invention relates to 3-hydroxyoxindole derivatives which have antagonistic activities against CRHR2, and which are useful in the treatment or prevention of disorders and diseases in which CRHR2 is involved. The invention also relates to pharmaceutical compositions comprising these compou...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
18.01.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to 3-hydroxyoxindole derivatives which have antagonistic activities against CRHR2, and which are useful in the treatment or prevention of disorders and diseases in which CRHR2 is involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CRHR2 is involved. |
---|---|
AbstractList | The present invention relates to 3-hydroxyoxindole derivatives which have antagonistic activities against CRHR2, and which are useful in the treatment or prevention of disorders and diseases in which CRHR2 is involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CRHR2 is involved. |
Author | OHMI, Masashi MAGARA, Ryohei ANDO, Kazuo |
Author_xml | – fullname: ANDO, Kazuo – fullname: MAGARA, Ryohei – fullname: OHMI, Masashi |
BookMark | eNrjYmDJy89L5WQwNNb1iHQJ8o-I9I_w9HPx93FVcHEN8gxzDPEMcw1WcAxWcA7yCDJScPQLcXT39_MMDuFhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGRiYGhhaGBsaOhsbEqQIAB80pYA |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US2024018103A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US2024018103A13 |
IEDL.DBID | EVB |
IngestDate | Fri Oct 25 05:44:03 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US2024018103A13 |
Notes | Application Number: US202118028062 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240118&DB=EPODOC&CC=US&NR=2024018103A1 |
ParticipantIDs | epo_espacenet_US2024018103A1 |
PublicationCentury | 2000 |
PublicationDate | 20240118 |
PublicationDateYYYYMMDD | 2024-01-18 |
PublicationDate_xml | – month: 01 year: 2024 text: 20240118 day: 18 |
PublicationDecade | 2020 |
PublicationYear | 2024 |
RelatedCompanies | RaQualia Pharma Inc |
RelatedCompanies_xml | – name: RaQualia Pharma Inc |
Score | 3.511194 |
Snippet | The present invention relates to 3-hydroxyoxindole derivatives which have antagonistic activities against CRHR2, and which are useful in the treatment or... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
Title | 3-HYDROXYOXINDOLE DERIVATIVES AS CRHR2 ANTAGONIST |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240118&DB=EPODOC&locale=&CC=US&NR=2024018103A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8BhT1DeditMpBaVvxXX9fijSNa2tuHb0i-5prCUFQbrhKv59L6XTPe0tycEluXC5j9xdAJ4mJSsjt8ITmBSFIKvUEAyqVQITpWOjUlXaFnueBaqXym-5kvfgc5cL09YJ_WmLIyJHlcjvTXtfb_6dWKSNrdw-Fx84tH5xE5PwnXWM4gkVZp5MTWcektDmbdtMYz6IOpgujiULbaUjVKQ1FgDmZFOWl7LZFyruORzPEV_dXECP1gM4tXd_rw3gZNY9eWOz477tJYiS4C1IFOaLMPcDEr47HEE7LLMSP3Nizoo5O_KiCWcFifUaBn6cXMGj6yS2J-Dcy7-tLtN4f6HSNfTrdU1vgCtVQyv0UmF0lWmlrnRFoZJCDUNTyqKUhjA6hOn2MPgOzliXuRZEfQT95uub3qOwbYqHlka_Sb184A |
link.rule.ids | 230,309,783,888,25578,76884 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsXp1ILSt-K2fqx9GNI1na32Y_SL7qmsJQNBuuEq_vteSqd72lvIwSW5cLmP5H4BeBoVDEZuiTswynNBUqgmaHS8EpgpHWgrRaE12LPrKVYsvaVy2oLPXS1MjRP6U4MjokYVqO9VfV5v_pNYpH5buX3OP7Br_TKLJoRvomM0T-gw82Q6Mec-8Q3eMCZxyHtBQ1OHA1HHWOkInWyVIe2byZTVpWz2jcrsDI7nyK-szqFFyy50jN3fa104cZsrb2w22re9gKEoWAsS-OnCT22P-I7JEYzDEj2yEzPk9JAzAisYcboX6a--Z4fRJTzOzMiwBBw7-1tqFof7ExWvoF2uS3oNXKFo41wtZCZXia6UpSrLVJSppo3lIi_EHvQPcbo5TH6AjhW5TubY3vstnDISSzMM1T60q69veoeGt8rva3n9Akytf9A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=3-HYDROXYOXINDOLE+DERIVATIVES+AS+CRHR2+ANTAGONIST&rft.inventor=ANDO%2C+Kazuo&rft.inventor=MAGARA%2C+Ryohei&rft.inventor=OHMI%2C+Masashi&rft.date=2024-01-18&rft.externalDBID=A1&rft.externalDocID=US2024018103A1 |